MRI of the Breast: Current Indications and Outlook to the Future
Magnetic resonance imaging (MRI) of the breast has gained widespread clinical acceptance due to a large effort in standardization of image acquisition and interpretation partly due to the extensive use of the Breast Imaging Reporting and Data System (BI-RADS) lexicon. The role of MRI of the breast has evolved from the traditional question about local recurrence of breast cancer to a variety of indications such as high-risk screening, evaluating response to neoadjuvant chemotherapy, staging and screening for contralateral cancer, occult primary breast cancer, and implant evaluation [1, 2]. This jump from a third-line breast-imaging technique to a primary imaging technique is also due to the increased availability of MRI-guided biopsy systems and an increasing awareness for standardized follow-up protocols and quality assurance for MRI-only lesions . This trend has encouraged newer indications, such as discordant radiopathologic findings, nipple discharge, or high-risk lesions after breast biopsy, for MRI of the breast to help solve complex clinical situations.
KeywordsBreast Cancer BRCA1 Mutation Carrier Breast Magnetic Resonance Imaging Fibrous Capsule Nipple Discharge
- 5.Sardanelli F, Podo F, Santoro F et al; High Breast Cancer Risk Italian 1 (HIBCRIT-1) Study (2011) Multicenter surveillance of women at high genetic breast cancer risk using mammography, ultrasonography, and contrast-enhanced magnetic resonance imaging (the high breast cancer risk Italian 1 study): final results. Invest Radiol 46:94–105.PubMedCrossRefGoogle Scholar